FDA Investigator Thomas W Gordon
Thomas W Gordon has inspections in 12 countries as of 09 May 2024. Thomas W Gordon has collaborated with a combined 3327 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
699
Last Inspection Date:
09 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
China,
United Kingdom of Great Britain and Northern Ireland,
Germany,
India,
Netherlands,
Argentina,
Serbia,
Canada,
Sweden,
Poland
Co-Investigator(s):
Alan L Truong,
Alanna Lmussawwir Bias,
Alex G Kalugin,
Amanda E Lewin, PhD,
Andersoneric,
Andrew E Kay,
Angela D Wise,
Anh M Lac,
Anna L Marroquin,
Annie H Lam,
Anothony E Keller, RPh, MPH,
Anthony E Keller, RPh,
Anthony N Onianwa,
Arindam Dasgupta, PhD,
Ashar P Parikh,
Azza Talaat,
Barbara J Rincon,
Blair,
Brian P Putz,
Bruce H Mccullough,
Carl Lee,
Carla J Lundi,
CDR Rochelle B Young, RPh, MSA,
Charles D Brown,
Christopher J Lee,
Christopher M Reed,
Cindy W Lewis,
Claudia Mperez Kasmarski,
Clinton J Lott,
Courtney N Long,
Courtney R Bolton,
Cynthia L Evitt,
Damon A Growl,
Daniel J Roberts,
Daniel L Aisen,
Darlene B Almogela,
Darneillej,
David G Eng,
David H Engelskirchen,
David X Gan,
Dejon N Harris,
Dena L Jacobs,
Deyaa Shaheen,
Dustin P Tran,
Elva M Ibarra,
Emmanuel O Kerry,
Erica L Nicoll,
Estefania Fernandez,
Gajendiran Mahadevan, PhD,
Garciam,
Gerald N Mcgirl, DDS,
Gulshan R Anand,
Gunneet Kaur,
Hasan A Irier, PhD,
Helen J Hamaoka,
Humberto Z Gomez,
Ingrid A Zambrana,
Ismael Garibay,
Ivis Lnegron Torres,
Jacobitz,
James A Barreto,
James A Liubicich,
James C Yee,
James W Whitney,
Jamie L Port,
Jane M Kreis,
Janete F Guardia,
Janice K Gardner,
Jazmine M Welcher,
Jeffrey M Watson,
Jeffrey P Raimondi,
Jennifer Crumb,
Jennifer L Degroot,
Jennifer L Johnson,
Jennifer S King,
Jessica B Darneille,
Joanne Hosting,
Joanne M Fukuda,
Joanne M Schlossin,
John A Gonzalez,
Jonathan M Mcbride,
Jorge L Bertran,
Joseph M Willems,
Joseph P Iser, MD,
Joseph R Haynes,
Joseph Tibay,
Joshua C Schafer,
Joy P Matthias,
Julia N Alvarez,
Julia Ventura,
Kara D Dobbin,
Karen J Bak,
Karen L Robles,
Karen M Willis,
Karin A Velasques,
Karla J Gibler,
Kathleen D Culver,
Katie T Duong,
Kawshalya Pathiraja,
Kelvin X Sanders,
Kenneth S Boehnen,
Kent A Conforti,
Kevin P Foley,
Lacresha Menifee,
Lam,
Lance M De Souza, MBA,
Lee,
Leongc,
Ligia M Cline,
Ligia M Sanders,
Lillian C Lopez,
Linda S Shook,
Lisa H Nakagawa,
Lisa K Capron,
Lloyd D Payne,
Lopez,
LT Mark A Chen, MPH,
Lucas B Leake,
Lucila B Nwatu,
Lynda L Perry, PhD,
Macropolk,
Maira P Brading,
Makini Cobourne Duval, PhD,
Marcus F Yambot,
Marie A Fadden,
Marie K Kinkade,
Marjorie D Santos,
Mark C Saale,
Mark E Baldwin,
Marshalette O Edwards,
Mary C Acton,
Matthew C Watson,
Matthew R Clabeaux,
Mcgrewp,
Melody M Ragasa Leong,
Michael D Garcia,
Michael S Call,
Michele M Falchek,
Minh D Phan,
Monique C Lo,
Mra Mcculloughj,
Myers,
Ngoc T Le,
Nicholas L Hunt,
Nicolas C Tolosa,
Nicole Yuen,
Phal K Chhun,
Phillip J Sample,
Randy L Elsberry,
Regina T Brown,
Richard H Penta,
Robert D Tollefsen,
Robles,
Rochelle A Rolnik,
Rochelle R Blair,
Ronald P Boyce,
Ruben C Ayala, PharmD,
Rumany C Penn, PharmD,
Sajin Bae,
Samuel J Barone, III,
Sandra S Saniga,
Sangeeta M Khurana, PhD,
Sara H Gabel,
Sara Jdent Acosta,
Satheesh Thomas,
Scott J Matsuda,
Scott N Lim,
Shaquenta Y Perkins,
Shelby N Turner,
Simone E Pitts,
Siobhan A Gallagher,
Sondra R Davis,
Sripal R Mada, PhD,
State Agency,
Stefanie R Cook,
Steven A Gonzales,
Steven D Kehoe,
Steven E Porter, Jr,
Steven M Galvez,
Stuart W Russell,
Taichun Qin, PhD,
Tammy Vasquez Hancock,
Theressa B Smith,
Tiffani D Wilson,
Timothy T Kapsala,
Tomanik'e C Banks,
Travelle D Mason,
Travis R Hunt,
Tristian E Strait,
Uduak M Inokon,
Uttaniti Limchumroon (Tom),
Victoria Taylor,
Willemsj,
William V Millar,
Xikui Chen (nmi), PhD
Thomas W Gordon's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more